NanoString releases first CosMx SMI dataset

By The Science Advisory Board staff writers

November 9, 2021 -- NanoString Technologies has released the first high-plex, single-cell in situ dataset from formalin-fixed paraffin-embedded (FFPE) tissue samples generated by its CosMx Spatial Molecular Imager (SMI).

Image of a protein morphology map relating to the CosMx SMI dataset.
The CosMx SMI dataset contains a protein morphology map that includes (A) a subcellular expression map of 960 genes, (B) cell segmentation, (C) a spatially resolved cell type map, and (D) non-small cell lung cancer tissues. Image courtesy of NanoString.

NanoString used the CosMx SMI to characterize FFPE tissue from eight different non-small cell lung cancer (NSCLC) samples from five patients. The SMI data creates a spatial cell atlas of NSCLC tissue by defining a subcellular expression map of 960 genes and a single-cell map of 18 identified cell types, the company said.

The CosMx SMI dataset consists of open-source, spatial in situ imaging and molecular data available from NanoString's website and analyzed by the research community. The complete dataset consists of over 800,000 single cells, approximately 260 million transcripts, and a spatially resolved cell type map of NSCLC tissue across a 150 mm2 area, NanoString said.

The CosMx SMI is expected to launch in the second half of 2022, according to the company.

NanoString uses tech to assess ties between tumor cells and immune cells
NanoString Technologies is directing attention to research published online August 26 in Cell involving its GeoMx Digital Spatial Profiler technology.
NanoString posts higher revenues, lower net loss in Q2
Record orders for its spatial molecular imager helped NanoString Technologies increase its total revenue and lower the company's net loss in the second...
NanoString releases nCounter stem cell characterization panel
NanoString Technologies has unveiled its nCounter stem cell characterization panel for the analysis and optimization of stem cell lines for humans and...
NanoString posts higher revenues, lower net loss in Q1
Strong growth in product and service revenues helped NanoString Technologies reach 18.8% total revenue growth and a lower net loss in its first quarter.
NanoString tech used to develop SARS-CoV-2 lung cell atlas
NanoString Technologies' GeoMX digital spatial profiler (DSP) technology has been used to develop a foundational dataset to better understand the biological...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter